Medicure Inc

NGQ1

Company Profile

  • Business description

    Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

  • Contact

    2 - 1250 Waverley Street
    WinnipegMBR3T 6C6
    CAN

    T: +1 204 487-7412

    E: [email protected]

    https://www.medicure.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2025

    Employees

    25

Stocks News & Analysis

video

Do you qualify as 'rich'?

Morningstar's Sim Mody speaks with Mark LaMonica about the varying definitions of rich. 
stocks

Solid sales from ASX healthcare leader

Solid device sales with shares moderately undervalued.
stocks

Megatrend Investing: ASX players to capitalise on the clean energy transition

Find out how you can benefit from global megatrends.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,683.4055.000.64%
CAC 407,891.6814.72-0.19%
DAX 4021,585.9380.230.37%
Dow JONES (US)44,680.08258.170.58%
FTSE 1008,623.2952.520.61%
HKSE20,597.09192.87-0.93%
NASDAQ19,647.136.89-0.04%
Nikkei 22538,831.4833.110.09%
NZX 50 Index12,844.5960.45-0.47%
S&P 5006,045.347.460.12%
S&P/ASX 2008,416.9037.500.45%
SSE Composite Index3,229.4921.11-0.65%

Market Movers